Technologies Available for Licensing
MONOCLONAL ANTIBODIES AND COMPLEMENTARITY-DETERMINING REGIONS BINDING TO EBOLA GLYPROTEIN
In this application are described Ebola GP monoclonal antibodies, epitopes recognized by these monoclonal antibodies, and the sequences of the variable regions of some of these antibodies. Also provided are mixtures of antibodies of the present invention, as well as methods of using individual antibodies or mixtures thereof for the detection, prevention, and/or therapeutical treatment of Ebola virus infections in vitro and in vivo.
Categories: Antibody Technologies,Vaccine
More Detail:Visit USPTO.GOV
Inventor(s):HART, M.; WILSON, J.